ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Compliance with OPTN Living Kidney Donor Follow-Up Policy Remains Low

A. Thomas1, A. Shaffer2, D. Segev2, M. Henderson2

1University of North Carolina, Chapel Hill, NC, 2Johns Hopkins, Baltimore, MD

Meeting: 2020 American Transplant Congress

Abstract number: 389

Keywords: Living donor

Session Information

Date: Saturday, May 30, 2020

Session Name: Quality Assurance Process Improvement & Regulatory Issues II

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:27pm-4:39pm

Location: Virtual

Related Abstracts
  • The Unfunded OPTN/UNOS Mandate of Living Kidney Donor Follow-Up: Fewer Than 50% of Centers in Compliance.
  • Living Liver Donor Follow-Up: Fewer Than Half of Centers Meet Follow-Up Requirements in the US

*Purpose: OPTN implemented a policy in 2013 that required all centers to perform 6-, 12-, and 24-month living donor follow-up (LDF). Early compliance with this policy was low, with less than 50% of centers compliant with complete and timely follow-up for living kidney donors. A policy change to be implemented in 2020 will expand the allowable reporting window. In order to assess whether follow-up has improved and the potential impact of the 2020 LDF policy change, we measured policy compliant LDF for living kidney donors through 2018.

*Methods: Using SRTR data on 33,861 living kidney donors between 02/2013 (policy start) and 12/2018, we studied LDF compliance as defined by OPTN, i.e. meeting thresholds for the proportion of complete LDF clinical and laboratory data submitted in a timely manner (60 days before or after the expected visit date). We also assessed complete follow-up ignoring the timeliness of submission. Donors transplanted in 2013-2016 were eligible for full 24-month LDF, 2017 donors were eligible for 6- and 12-month LDF, and 2018 donors were eligible for 6-month LDF.

*Results: Only 32 out of 219 (15%) of centers remained fully compliant with follow-up since the policy began in 2013. Ignoring the current 120-day reporting window, 71 (32%) centers met LDF completion thresholds since 2013. The total proportion of complete and timely 6-month LDF forms has plateaued since 2016 (Figure 1). No more than 50% of centers met complete and timely 6-, 12-, and 24-month follow-up for a given annual cohort of donors (Table 1).

*Conclusions: Compliance with the living kidney donor follow-up policy has not improved since the last national study. For a given annual cohort of donors, no more than 50% of centers met the OPTN requirements for 6-, 12-, and 24-month follow-up. Expanding the data submission window might improve compliance rates, but donor- or center-level interventions will be necessary to significantly improve follow-up of living kidney donors.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Thomas A, Shaffer A, Segev D, Henderson M. Compliance with OPTN Living Kidney Donor Follow-Up Policy Remains Low [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/compliance-with-optn-living-kidney-donor-follow-up-policy-remains-low/. Accessed March 8, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.